Clinical Trial Update: A Safety and Biodistribution Study of [I-124]-CPD-1028 Injection in Solid Tumours [Phase 1]

View source ↗

Summary

Phase 1 safety and biodistribution study of [I-124]-CPD-1028 in solid tumors has completed, according to the trial record.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• [I-124]-CPD-1028 Injection (CPD-1028 radiopharmaceutical)

Snippet

Sponsor: Centre for Probe Development and Commercialization | Conditions: Cancer | Phase 1 | Status: COMPLETED